Clinical outcomes of modified post‐transplantation cyclophosphamide versus granulocyte colony‐stimulating factor/anti‐thymocyte globulin‐based protocol in alternative donor transplantation for severe aplastic anaemia

Documenti analoghi

• Phase II trial of posaconazole prophylaxis during anti‐thymocyte globulin treatment for aplastic anaemia and hypoplastic myelodysplastic syndrome
  di: Dong Hyun Kim, et al.
  Pubblicazione: (2024)
• Outcomes with low dose anti‐thymocyte globulin based graft versus host disease prophylaxis after mismatched unrelated donor allogeneic hematopoietic cell transplantation
  di: Hafsah Chalchal, et al.
  Pubblicazione: (2024)
• Excellent outcomes in children after haematopoietic stem cell transplantation for hepatitis‐associated aplastic anaemia following liver transplantation
  di: Satish Kumar Meena, et al.
  Pubblicazione: (2026)
• Clinical and genetic profiles and outcomes of allogeneic haematopoietic stem cell transplantation in secondary myelodysplastic syndrome following aplastic anaemia
  di: Jia Li, et al.
  Pubblicazione: (2024)
• Allogeneic blood or marrow transplantation using haploidentical grandchildren donors and post‐transplant cyclophosphamide‐based graft‐versus‐host disease prophylaxis
  di: Yosra M. Aljawai, et al.
  Pubblicazione: (2024)